Toll-like receptor 4 mediates lipopolysaccharide-induced muscle catabolism via coordinate activation of ubiquitin-proteasome and autophagy-lysosome pathways

FASEB Journal

Volumn 25, Issue 1, 2011, Pages 99-110

  Doyle, Alexander ^a   Zhang, Guohua ^a   Abdel Fattah, Elmoataz A ^b   Eissa, N Tony ^b   Li, Yi Ping ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

3 Methyladenine; Atrogin 1 MAFbx; Autophagosomes; Lactacystin; p38 MAPK

Indexed keywords

ATROGIN 1; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE 1; MUSCLE RING FINGER 1 PROTEIN; SYNAPTOPHYSIN; TOLL LIKE RECEPTOR 4; UBIQUITIN; UBIQUITIN PROTEIN LIGASE;

ANIMAL EXPERIMENT; ARTICLE; AUTOPHAGY; CATABOLISM; CONTROLLED STUDY; LYSOSOME; MALE; MOUSE; MYOTUBE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; UPREGULATION;

ANIMALS; AUTOPHAGY; BLOTTING, WESTERN; CELL LINE; ENZYME INHIBITORS; IMIDAZOLES; LIPOPOLYSACCHARIDES; LYSOSOMES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUSCLE FIBERS, SKELETAL; MUSCLE PROTEINS; MUSCLES; MUSCULAR ATROPHY; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHAGOSOMES; PROTEASOME ENDOPEPTIDASE COMPLEX; PYRIDINES; RNA INTERFERENCE; SIGNAL TRANSDUCTION; SKP CULLIN F-BOX PROTEIN LIGASES; TOLL-LIKE RECEPTOR 4; UBIQUITIN;

MUS;

EID: 79251582476     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.10-164152     Document Type: Article

References (57)

1. Evans, W. J., Morley, J. E., Argiles, J., Bales, C., Baracos, V., Guttridge, D., Jatoi, A., Kalantar-Zadeh, K., Lochs, H., Mantovani, G., Marks, D., Mitch, W. E., Muscaritoli, M., Najand, A., Ponikowski, P., Rossi Fanelli, F., Schambelan, M., Schols, A., Schuster, M., Thomas, D., Wolfe, R., and Anker, S. D. (2008) Cachexia: a new definition. Clin. Nutr. 27, 793-799
2. Solomon, V., and Goldberg, A. L. (1996) Importance of the ATP-ubiquitin-proteasome pathway in the degradation of soluble and myofibrillar proteins in rabbit muscle extracts. J. Biol. Chem. 271, 26690-26697
3. Bechet, D., Tassa, A., Taillandier, D., Combaret, L., and Attaix, D. (2005) Lysosomal proteolysis in skeletal muscle. Int. J. Biochem. Cell Biol. 37, 2098-2114
4. Kirkin, V., McEwan, D. G., Novak, I., and Dikic, I. (2009) A role for ubiquitin in selective autophagy. Mol. Cell 34, 259-269
5. Lecker, S. H., Goldberg, A. L., and Mitch, W. E. (2006) Protein degradation by the ubiquitin-proteasome pathway in normal and disease states. J. Am. Soc. Nephrol. 17, 1807-1819
6. Bodine, S. C., Latres, E., Baumhueter, S., Lai, V. K., Nunez, L., Clarke, B. A., Poueymirou, W. T., Panaro, F. J., Na, E., Dharmarajan, K., Pan, Z. Q., Valenzuela, D. M., DeChiara, T. M., Stitt, T. N., Yancopoulos, G. D., and Glass, D. J. (2001) Identification of ubiquitin ligases required for skeletal muscle atrophy. Science 294, 1704-1708
7. Gomes, M. D., Lecker, S. H., Jagoe, R. T., Navon, A., and Goldberg, A. L. (2001) Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy. Proc. Natl. Acad. Sci. U. S. A. 98, 14440-14445
8. Sandri, M., Sandri, C., Gilbert, A., Skurk, C., Calabria, E., Picard, A., Walsh, K., Schiaffino, S., Lecker, S. H., and Goldberg, A. L. (2004) Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell 117, 399-412
9. Stitt, T. N., Drujan, D., Clarke, B. A., Panaro, F., Timofeyva, Y., Kline, W. O., Gonzalez, M., Yancopoulos, G. D., and Glass, D. J. (2004) The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors. Mol. Cell 14, 395-403
10. Sacheck, J. M., Hyatt, J. P., Raffaello, A., Jagoe, R. T., Roy, R. R., Edgerton, V. R., Lecker, S. H., and Goldberg, A. L. (2007) Rapid disuse and denervation atrophy involve transcriptional changes similar to those of muscle wasting during systemic diseases. FASEB J. 21, 140-155
11. Argiles, J. M., Alvarez, B., Carbo, N., Busquets, S., Van Royen, M., and Lopez-Soriano, F. J. (2000) The divergent effects of tumour necrosis factor-alpha on skeletal muscle: implications in wasting. Eur. Cytokine Netw. 11, 552-559
12. Moylan, J. S., Smith, J. D., Chambers, M. A., McLoughlin, T. J., and Reid, M. B. (2008) TNF induction of atrogin-1/MAFbx mRNA depends on Foxo4 expression but not AKT-Foxo1/3 signaling. Am. J. Physiol. Cell Physiol. 295, C986-C993
13. Li, Y. P., Chen, Y., John, J., Moylan, J., Jin, B., Mann, D. L., and Reid, M. B. (2005) TNF-alpha acts via p38 MAPK to stimulate expression of the ubiquitin ligase atrogin1/MAFbx in skeletal muscle. FASEB J. 19, 362-370
14. Cai, D., Frantz, J. D., Tawa, N. E., Jr., Melendez, P. A., Oh, B. C., Lidov, H. G., Hasselgren, P. O., Frontera, W. R., Lee, J., Glass, D. J., and Shoelson, S. E. (2004) IKKβ/NF-κB activation causes severe muscle wasting in mice. Cell 119, 285-298
15. Goldberg, R. M., Loprinzi, C. L., Mailliard, J. A., O'Fallon, J. R., Krook, J. E., Ghosh, C., Hestorff, R. D., Chong, S. F., Reuter, N. F., and Shanahan, T. G. (1995) Pentoxifylline for treatment of cancer anorexia and cachexia? A randomized, double-blind, placebo-controlled trial. J. Clin. Oncol. 13, 2856-2859
16. Liu, K. H., Liao, L. M., Ro, L. S., Wu, Y. L., and Yeh, T. S. (2008) Thalidomide attenuates tumor growth and preserves fast-twitch skeletal muscle fibers in cholangiocarcinoma rats. Surgery 143, 375-383
17. Li, W., Moylan, J. S., Chambers, M. A., Smith, J., and Reid, M. B. (2009) Interleukin-1 stimulates catabolism in C2C12 myotubes. Am. J. Physiol. Cell Physiol. 297, C706-C714
18. Baltgalvis, K. A., Berger, F. G., Pena, M. M., Davis, J. M., White, J. P., and Carson, J. A. (2009) Muscle wasting and interleukin-6-induced atrogin-I expression in the cachectic Apc (Min/+) mouse. Pflug̈ers Arch. 457, 989-1001
19. Zhao, J., Brault, J. J., Schild, A., Cao, P., Sandri, M., Schiaffino, S., Lecker, S. H., and Goldberg, A. L. (2007) FoxO3 coordinately activates protein degradation by the autophagic/lysosomal and proteasomal pathways in atrophying muscle cells. Cell. Metab. 6, 472-483
20. Mammucari, C., Milan, G., Romanello, V., Masiero, E., Rudolf, R., Del Piccolo, P., Burden, S. J., Di Lisi, R., Sandri, C., Zhao, J., Goldberg, A. L., Schiaffino, S., and Sandri, M. (2007) FoxO3 controls autophagy in skeletal muscle in vivo. Cell. Metab. 6, 458-471
21. Zhao, J., Brault, J. J., Schild, A., and Goldberg, A. L. (2008) Coordinate activation of autophagy and the proteasome pathway by FoxO transcription factor. Autophagy 4, 378-380
22. Rosenblatt, S., Clowes, G. H., Jr., George, B. C., Hirsch, E., and Lindberg, B. (1983) Exchange of amino acids by muscle and liver in sepsis. Arch. Surg. 118, 167-175
23. Hasselgren, P. O., Talamini, M., James, J. H., and Fischer, J. E. (1986) Protein metabolism in different types of skeletal muscle during early and late sepsis in rats. Arch. Surg. 121, 918-923
24. Hasselgren, P. O., James, J. H., Benson, D. W., Hall-Angeras, M., Angeras, U., Hiyama, D. T., Li, S., and Fischer, J. E. (1989) Total and myofibrillar protein breakdown in different types of rat skeletal muscle: effects of sepsis and regulation by insulin. Metabolism 38, 634-640
25. Tiao, G., Fagan, J. M., Samuels, N., James, J. H., Hudson, K., Lieberman, M., Fischer, J. E., and Hasselgren, P. O. (1994) Sepsis stimulates nonlysosomal, energy-dependent proteolysis and increases ubiquitin mRNA levels in rat skeletal muscle. J. Clin. Invest. 94, 2255-2264
26. Tiao, G., Hobler, S., Wang, J. J., Meyer, T. A., Luchette, F. A., Fischer, J. E., and Hasselgren, P. O. (1997) Sepsis is associated with increased mRNAs of the ubiquitin-proteasome proteolytic pathway in human skeletal muscle. J. Clin. Invest. 99, 163-168
27. Wray, C. J., Mammen, J. M., Hershko, D. D., and Hasselgren, P. O. (2003) Sepsis upregulates the gene expression of multiple ubiquitin ligases in skeletal muscle. Int. J. Biochem. Cell Biol. 35, 698-705
28. Dehoux, M. J., van Beneden, R. P., Fernandez-Celemin, L., Lause, P. L., and Thissen, J. P. (2003) Induction of MafBx and Murf ubiquitin ligase mRNAs in rat skeletal muscle after LPS injection. FEBS Lett. 544, 214-217
29. Vary, T. C. (1998) Regulation of skeletal muscle protein turnover during sepsis. Curr. Opin. Clin. Nutr. Metab. Care 1, 217-224
30. Han, D. M., Zhang, Y. Q., Bai, Q. X., and Chen, X. Q. (2007) Assay of AVP, CRP, and LPS in leukemia. Int. J. Lab. Hematol. 29, 185-189
31. Niebauer, J., Volk, H. D., Kemp, M., Dominguez, M., Schumann, R. R., Rauchhaus, M., Poole-Wilson, P. A., Coats, A. J., and Anker, S. D. (1999) Endotoxin and immune activation in chronic heart failure: a prospective cohort study. Lancet 353, 1838-1842
32. Al-Attas, O. S., Al-Daghri, N. M., Al-Rubeaan, K., da Silva, N. F., Sabico, S. L., Kumar, S., McTernan, P. G., and Harte, A. L. (2009) Changes in endotoxin levels in T2DM subjects on anti-diabetic therapies. Cardiovasc. Diabetol. 8, 20
33. Takeda, K., and Akira, S. (2001) Regulation of innate immune responses by Toll-like receptors. Jpn. J. Infect. Dis. 54, 209-219 (Pubitemid 34285466)
34. Janssens, S., and Beyaert, R. (2003) Role of Toll-like receptors in pathogen recognition. Clin. Microbiol. Rev. 16, 637-646
35. Takeda, K., and Akira, S. (2005) Toll-like receptors in innate immunity. Int. Immunol. 17, 1-14
36. Takeda, K., and Akira, S. (2004) TLR signaling pathways. Semin. Immunol. 16, 3-9
37. Xu, Y., Liu, X. D., Gong, X., and Eissa, N. T. (2008) Signaling pathway of autophagy associated with innate immunity. Autophagy 4, 110-112
38. Moylan, J. S., and Reid, M. B. (2007) Oxidative stress, chronic disease, and muscle wasting. Muscle Nerve 35, 411-429
39. Lang, C. H., Silvis, C., Deshpande, N., Nystrom, G., and Frost, R. A. (2003) Endotoxin stimulates in vivo expression of inflammatory cytokines tumor necrosis factor alpha, interleukin-1beta, -6, and high-mobility-group protein-1 in skeletal muscle. Shock 19, 538-546
40. Boyd, J. H., Divangahi, M., Yahiaoui, L., Gvozdic, D., Qureshi, S., and Petrof, B. J. (2006) Toll-like receptors differentially regulate CC and CXC chemokines in skeletal muscle via NF-κB and calcineurin. Infect. Immun. 74, 6829-6838
41. Xu, Y., Jagannath, C., Liu, X. D., Sharafkhaneh, A., Kolodziejska, K. E., and Eissa, N. T. (2007) Toll-like receptor 4 is a sensor for autophagy associated with innate immunity. Immunity 27, 135-144
42. Mizushima, N., Yamamoto, A., Matsui, M., Yoshimori, T., and Ohsumi, Y. (2004) In vivo analysis of autophagy in response to nutrient starvation using transgenic mice expressing a fluorescent autophagosome marker. Mol. Biol. Cell 15, 1101-1111
43. Hoshino, K., Takeuchi, O., Kawai, T., Sanjo, H., Ogawa, T., Takeda, Y., Takeda, K., and Akira, S. (1999) Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J. Immunol. 162, 3749-3752
44. Thomas, M., Lu, J. J., Ge, Q., Zhang, C., Chen, J., and Klibanov, A. M. (2005) Full deacylation of polyethylenimine dramatically boosts its gene delivery efficiency and specificity to mouse lung. Proc. Natl. Acad. Sci. U. S. A. 102, 5679-5684
45. Huang, S., Jiang, Y., Li, Z., Nishida, E., Mathias, P., Lin, S., Ulevitch, R. J., Nemerow, G. R., and Han, J. (1997) Apoptosis signaling pathway in T cells is composed of ICE/Ced-3 family proteases and MAP kinase kinase 6b. Immunity 6, 739-749
46. Menconi, M., Gonnella, P., Petkova, V., Lecker, S., and Hasselgren, P. O. (2008) Dexamethasone and corticosterone induce similar, but not identical, muscle wasting responses in cultured L6 and C2C12 myotubes. J. Cell. Biochem. 105, 353-364
47. Fulks, R. M., Li, J. B., and Goldberg, A. L. (1975) Effects of insulin, glucose, and amino acids on protein turnover in rat diaphragm. J. Biol. Chem. 250, 290-298
48. Waalkes, T. P., and Udenfriend, S. (1957) A fluorometric method for the estimation of tyrosine in plasma and tissues. J. Lab. Clin. Med. 50, 733-736
49. Doan, H. Q., Bowen, K. A., Jackson, L. A., and Evers, B. M. (2009) Toll-like receptor 4 activation increases Akt phosphorylation in colon cancer cells. Anticancer Res. 29, 2473-2478
50. Brunet, A., Bonni, A., Zigmond, M. J., Lin, M. Z., Juo, P., Hu, L. S., Anderson, M. J., Arden, K. C., Blenis, J., and Greenberg, M. E. (1999) Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96, 857-868
51. Jin, B., and Li, Y. P. (2007) Curcumin prevents lipopolysaccharide- induced atrogin-1/MAFbx upregulation and muscle mass loss. J. Cell. Biochem. 100, 960-969
52. Klionsky, D. J., Abeliovich, H., Agostinis, P., Agrawal, D. K., Aliev, G., Askew, D. S., Baba, M., Baehrecke, E. H., Bahr, B. A., Ballabio, A., Bamber B. A., Bassham, D. C., Bergamini, E., Bi, X., Biard-Piechaczyk, M., Blum, J. S., Bredesen, D. E., Brodsky, J. L., Brumell, J. H., Brunk, U. T., Bursch, W., Camougrand, N., Cebollero, E., Cecconi, F., Chen, Y., Chin, L. S., Choi, A., Chu, C. T., Chung, J., Clarke, P. G., Clark, R. S., Clarke, S. G., Clavé, C., Cleveland, J. L., Codogno, P., Colombo, M. I., Coto-Montes, A., Cregg, J. M., Cuervo, A. M., Debnath, J., Demarchi, F., Dennis, P. B., Dennis, P. A., Deretic, V., Devenish, R. J., Di Sano, F., Dice, J. F., Difiglia, M., Dinesh-Kumar, S., Distelhorst, C. W., Djavaheri-Mergny, M., Dorsey, F. C., Drog̈e, W., Dron, M., Dunn, W. A., Jr., Duszenko, M., Eissa, N. T., Elazar, Z., Esclatine, A., Eskelinen, E. L., Fesüs, L., Finley, K. D., Fuentes, J. M., Fueyo, J., Fujisaki, K., Galliot, B., Gao, F. B., Gewirtz, D. A., Gibson, S. B., Gohla, A., Goldberg, A. L., Gonzalez, R., González-Estévez, C., Gorski, S., Gottlieb, R. A., Häussinger, D., He, Y. W., Heidenreich, K., Hill, J. A., Høyer-Hansen, M., Hu, X., Huang, W. P., Iwasaki, A., Jäättelä, M., Jackson, W. T., Jiang, X., Jin, S., Johansen, T., Jung, J. U., Kadowaki, M., Kang, C., Kelekar, A., Kessel, D. H., Kiel, J. A., Kim, H. P., Kimchi, A., Kinsella, T. J., Kiselyov, K., Kitamoto, K., Knecht, E., Komatsu, M., Kominami, E., Kondo, S., Kovács, A. L., Kroemer, G., Kuan, C. Y., Kumar, R., Kundu, M., Landry, J., Laporte, M., Le, W., Lei, H. Y., Lenardo, M. J., Levine, B., Lieberman, A., Lim, K. L., Lin, F. C., Liou, W., Liu, L. F., Lopez-Berestein, G., López-Otín, C., Lu, B., Macleod, K. F., Malorni, W., Martinet, W., Matsuoka, K., Mautner, J., Meijer, A. J., Meléndez, A., Michels, P., Miotto, G., Mistiaen, W. P., Mizushima, N., Mograbi, B., Monastyrska, I., Moore, M. N., Moreira, P. I., Moriyasu, Y., Motyl, T., Münz, C., Murphy, L. O., Naqvi, N. I., Neufeld, T. P., Nishino, I., Nixon, R. A., Noda, T., Nürnberg, B., Ogawa, M., Oleinick, N. L., Olsen, L. J., Ozpolat, B., Paglin, S., Palmer, G. E., Papassideri, I., Parkes, M., Perlmutter, D. H., Perry, G., Piacentini, M., Pinkas-Kramarski, R., Prescott, M., Proikas-Cezanne, T., Raben, N., .Rami, A., Reggiori, F., Rohrer, B., Rubinsztein, D. C., Ryan, K. M., Sadoshima, J., Sakagami, H., Sakai, Y., Sandri, M., Sasakawa, C., Sass, M., Schneider, C., Seglen, P. O., Seleverstov, O., Settleman, J., Shacka, J. J., Shapiro, I. M., Sibirny, A., Silva-Zacarin, E. C., Simon, H. U., Simone, C., Simonsen, A., Smith, M. A., Spanel-Borowski, K., Srinivas, V., Steeves, M., Stenmark, H., Stromhaug, P. E., Subauste, C. S., Sugimoto, S., Sulzer, D., Suzuki, T., Swanson, M. S., Tabas, I., Takeshita, F., Talbot, N. J., Tallóczy, Z., Tanaka, K., Tanaka, K., Tanida, I., Taylor, G. S., Taylor, J. P., Terman, A., Tettamanti, G., Thompson, C. B., Thumm, M., Tolkovsky, A. M., Tooze, S. A., Truant, R., Tumanovska, L. V., Uchiyama, Y., Ueno, T., Uzcátegui, N. L., van der Klei, I., Vaquero, E. C., Vellai, T., Vogel, M. W., Wang, H. G., Webster, P., Wiley, J. W., Xi, Z., Xiao, G., Yahalom, J., Yang, J. M., Yap, G., Yin, X. M., Yoshimori, T., Yu, L., Yue, Z., Yuzaki, M., Zabirnyk, O., Zheng, X., Zhu, X., and Deter, R. L. (2008) Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy 4, 151-175
53. Seglen, P. O., and Gordon, P. B. (1982) 3-Methyladenine: specific inhibitor of autophagic/lysosomal protein degradation in isolated rat hepatocytes. Proc. Natl. Acad. Sci. U. S. A. 79, 1889-1892
54. Li, Y. P., Chen, Y., Li, A. S., and Reid, M. B. (2003) Hydrogen peroxide stimulates ubiquitin-conjugating activity and expression of genes for specific E2 and E3 proteins in skeletal muscle myotubes. Am. J. Physiol. Cell Physiol. 285, C806-C812
55. Tsan, M. F., and Gao, B. (2004) Endogenous ligands of Toll-like receptors. J. Leukoc. Biol. 76, 514-519
56. Ehrchen, J. M., Sunderkotter, C., Foell, D., Vogl, T., and Roth, J. (2009) The endogenous Toll-like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer. J. Leukoc. Biol. 86, 557-566
57. Masiero, E., Agatea, L., Mammucari, C., Blaauw, B., Loro, E., Komatsu, M., Metzger, D., Reggiani, C., Schiaffino, S., and Sandri, M. (2009) Autophagy is required to maintain muscle mass. Cell. Metab. 10, 507-515